Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Sabre Unlocks New Opportunities For Hoteliers - Read How

Sabre Corp (NASDAQ:SABR) has agreed to acquire Nuvola, a provider of hotel service optimization and guest engagement software to hoteliers, for an undisclosed sum. The transaction includes Nuvola technology and guest enablement software and the integration of Nuvola employees to Sabre. Nuvola equips hotels with cloud-based solutions, including task management capabilities, guest messaging…

Benzinga

Why This Analyst Thinks Tabula Rasa's Divestiture Plans 'An Important Step'

RBC Capital Markets believe that the market has been assigning little-to-no value to Tabula Rasa HealthCare Inc's (NASDAQ: TRHC) MedWise, which has been burning cash and clouding, a strong core PACE business.

Benzinga

Analysts Expect Clarity Imminent On Intercept's NASH Story

RBC Capital Markets writes that following the Advanz deal, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) should be well-capitalized into make-or-break upcoming readouts for obeticholic acid (OCA) in NASH, with REGENERATE re-analyses on deck, REVERSE reading in the next quarter. The analysts say it remains challenging to get visibility on how the efficacy/safety analyses will look,…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Illumina Shares Are Plunging Today?

A jury in the U.S. District Court for the District of Delaware rendered a verdict that Illumina Inc (NASDAQ:ILMN) willfully infringed the U.S. Patent Nos. 9,222,132 and 10,662,473 owned by Complete Genomics Inc. The jury awarded approximately $334 million to CGI in past damages. The jury also invalidated three patents owned by Illumina, namely, U.S.…

Benzinga

Why Hemisphere Media Shares Are Soaring Today

Gato Investments LP agreed to acquire Hemisphere Media Group, Inc (NASDAQ:HMTV) at $7 per share. The offer price implies a premium of 86% over Hemisphere's closing share price on May 6, the last trading day before the announcement. Hemisphere will become a private company wholly owned by Gato. Hemisphere CEO Alan Sokol said,…

Benzinga

Zai Lab's Earnings Outlook

Zai Lab (NASDAQ:ZLAB) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Zai Lab will report an earnings per share (EPS) of $-1.20.

Benzinga

Omeros Earnings Preview

Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Omeros will report an earnings per share (EPS) of $-0.71.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

A Preview Of Opiant Pharmaceuticals's Earnings

Opiant Pharmaceuticals (NASDAQ:OPNT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Opiant Pharmaceuticals will report an earnings per share (EPS) of $-0.91.

Benzinga

Earnings Preview For Urban-gro

Urban-gro (NASDAQ:UGRO) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Urban-gro will report an earnings per share (EPS) of $-0.05.

Benzinga

Earnings Outlook For Fuel Tech

Fuel Tech (NASDAQ:FTEK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Fuel Tech will report an earnings per share (EPS) of $-0.02.

Benzinga

ShotSpotter's Earnings Outlook

ShotSpotter (NASDAQ:SSTI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that ShotSpotter will report an earnings per share (EPS) of $0.09.

Benzinga

Analyst Ratings for Starbucks

Starbucks (NASDAQ:SBUX) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Preview: Gulf Island Fabrication

Gulf Island Fabrication (NASDAQ:GIFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Gulf Island Fabrication will report an earnings per share (EPS) of $-0.17.

Benzinga

Why 'Amazon of Argentina' MercadoLibre Stock Looks Set To Bounce

MercadoLibre, Inc (NASDAQ: MELI) was plummeting an additional 13% lower on Monday to reach a 52-week low, after having plunged over 10% between May 5 and the start of the trading day.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyst Ratings for Intercept Pharmaceuticals

Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter:

Benzinga

Earnings Outlook For Porch Group

Porch Group (NASDAQ:PRCH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Porch Group will report an earnings per share (EPS) of $-0.20.

Benzinga

Amid Domestic Violence Allegation, Longtime Seagen CEO Takes Leave of Absence

The Board of Directors of Seagen Inc (NASDAQ:SGEN) announced that its long-time president, CEO, and chairman Clay Siegall, is on a leave of absence. The move follows an alleged incident of domestic violence. While Siegall, who informed the company that he's in the middle of a divorce, denied those allegations. The Seagen board…

Benzinga

Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies

Twist Bioscience Corporation (NASDAQ:TWST) has entered into a research collaboration and exclusive option license agreement with Astellas Pharma Inc (OTC:ALPMF) to conduct research activities to identify and optimize proprietary Twist antagonist antibodies. The antibodies will target an undisclosed checkpoint inhibitor pathway in the tumor microenvironment as potential therapeutic development candidates. Ligands in this pathway are…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

12 Industrials Stocks Moving In Monday's Intraday Session

Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga

11 Information Technology Stocks Moving In Monday's Intraday Session

Benzinga

10 Financials Stocks Moving In Monday's Intraday Session

Benzinga

Jim Cramer Unimpressed By Palantir Earnings: Why He Says The Software Stock Is 'Doing So Poorly'

The overall markets continue to decline as earnings season unfolds. Monday on CNBC's "Squawk On The Street," Jim Cramer pointed out a concerning commonality among smaller companies that have reported recently.

Benzinga

Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus

Viatris Inc (NASDAQ:VTRS) reported Q1 FY22 sales of $4.18 billion, down 5% Y/Y (-1% on an operational basis), below the consensus of $4.23 billion. Brands performed better than expectations, such as Lipitor, Effexor, and Perforomist. Complex generics and biosimilars grew by 21% Y/Y on an operational basis, driven mainly by the generic…

Benzinga

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

1 … 503 504 505 506

People

Jim Cramer

478 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.